Clinical Trial Update: Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan with cisplatin for high-grade neuroendocrine carcinoma of the gastrointestinal tract has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Neuroendocrine Carcinoma Gastrointestinal Tract

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastrointestinal Cancer, Carcinoma, Neuroendocrine | Phase 2 | Status: COMPLETED